Key facts
- It has raised $14.1M.
- Notable investors include CAS Star, CAS Investment Management, Insight Capital (Taicang), Beijing Taiya Yusong Private Equity Fund Management Co., Chempartner Pharmatech — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Zheyuan Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zheyuan Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zheyuan Technology
Operator of a platform for drug research and development designed for tumors. The company offers artificial intelligence+ disease-driven drug research and development that can solve the problem of unclear pathogenic mechanisms, thereby enabling clients to improve drug development efficiency.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2015
- Employees
- 22
- Website
- philrivers.com/
- Ownership
- Privately Held (backing)
Zheyuan Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zheyuan Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zheyuan Technology in its N-PORT filings yet. We sweep new filings monthly.